XFOR Net Tangible Assets from 2010 to 2026
| XFOR Stock | USD 4.05 -0.18 -4.26% |
Net Tangible Assets | First Reported 2017-12-31 | Previous Quarter 34.3 M | Current Value 50.2 M | Quarterly Volatility 45.9 M |
Macro event markers
Evaluating X4 Pharmaceuticals's Net Tangible Assets across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into X4 Pharmaceuticals's fundamental strength.
Latest X4 Pharmaceuticals' Net Tangible Assets Growth Pattern
Below is the plot of the Net Tangible Assets of X4 Pharmaceuticals over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. X4 Pharmaceuticals' Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in X4 Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Net Tangible Assets | 10 Years Trend |
|
Net Tangible Assets |
| Timeline |
XFOR Net Tangible Assets Regression Statistics
| Arithmetic Mean | 12,684,544 | |
| Coefficient Of Variation | 404.99 | |
| Mean Deviation | 46,724,223 | |
| Median | -23,052,000 | |
| Standard Deviation | 51,371,097 | |
| Sample Variance | 2639T | |
| Range | 179.2M | |
| R-Value | 0.73 | |
| Mean Square Error | 1304.2T | |
| R-Squared | 0.54 | |
| Significance | 0.0008 | |
| Slope | 7,452,686 | |
| Total Sum of Squares | 42223.8T |
XFOR Net Tangible Assets History
Methodology, Assumptions & Data Sources
Reference-level detail on Net Tangible Assets allows deeper analysis of X4 Pharmaceuticals's operating trajectory. R-squared values indicate how well a linear model fits the historical trajectory.
This section for X4 Pharmaceuticals is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Analyst inputs may be included when coverage is available. Values may update on different source schedules. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.